36 related articles for article (PubMed ID: 19394201)
1. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of Acyclovir loaded nano-niosomes against herpes simplex virus type-1 in cell culture.
Monavari SH; Mirzaei Parsa MJ; Bolouri B; Ebrahimi SA; Ataei-Pirkooh A
Med J Islam Repub Iran; 2014; 28():99. PubMed ID: 25664300
[TBL] [Abstract][Full Text] [Related]
3. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
Sitohy M; Billaudel S; Haertlé T; Chobert JM
J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
8. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
9. Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents.
Wentland MP; Perni RB; Dorff PH; Brundage RP; Castaldi MJ; Carlson JA; Bailey TR; Aldous SC; Carabateas PM; Bacon ER; Kullnig RK; Young DC; Woods MG; Kingsley SD; Ryan KA; Rosi D; Drozd ML; Dutko FJ
Drug Des Discov; 1997 May; 15(1):25-38. PubMed ID: 9332829
[TBL] [Abstract][Full Text] [Related]
10. [Anti alpha-herpesvirus drugs].
Koshizuka T; Suzutani T
Nihon Rinsho; 2012 Apr; 70(4):558-63. PubMed ID: 22568134
[TBL] [Abstract][Full Text] [Related]
11. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
12. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy.
De Clercq E; Field HJ
Br J Pharmacol; 2006 Jan; 147(1):1-11. PubMed ID: 16284630
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]